Effect of azidothymidine (AZT) on P24 antigen levels in patients with AIDS‐related complex and AIDS
- 1 January 1989
- journal article
- research article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 3 (4) , 199-201
- https://doi.org/10.1002/jcla.1860030402
Abstract
Circulating HIV P24 antigen levels at baseline and following AZT therapy were measured in 9 patients with ARC and 11 patients with AIDS. Eight of these patients had no detectable levels of P24. The P24 antigen levels in the remaining 12 patients decreased significantly after AZT treatment. Following discontinuation of AZT treatment in 2 patients, the P24 antigen levels went up. These results clearly demonstrate the efficacy of AZT in reducing P24 antigen levels in circulation.Keywords
This publication has 15 references indexed in Scilit:
- AzidothymidineThe Journal of Infectious Diseases, 1988
- EFFECT OF ZIDOVUDINE ON SERUM HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN LEVELS IN SYMPTOM-FREE SUBJECTSThe Lancet, 1988
- RESUMPTION OF HIV ANTIGEN PRODUCTION DURING CONTINUOUS ZIDOVUDINE TREATMENTThe Lancet, 1988
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Strategies for antiviral therapy in AIDSNature, 1987
- Human Tumor and Immunodeficiency VirusesAIDS Research and Human Retroviruses, 1987
- Significant Changes in HIV Antigen Level in the Serum of Patients Treated with AzidothymidineNew England Journal of Medicine, 1986
- Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS.BMJ, 1986
- SEROLOGICAL MARKERS IN EARLY STAGES OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN HAEMOPHILIACSThe Lancet, 1986
- EXPRESSION OF HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN (HIV-Ag) IN SERUM AND CEREBROSPINAL FLUID DURING ACUTE AND CHRONIC INFECTIONThe Lancet, 1986